Immunochemotherapy Alone or Immunochemotherapy Plus Subsequent Locoregional Radiotherapy in De Novo Metastatic Nasopharyngeal Carcinoma.
ORAL ONCOLOGY(2023)
Abstract
•Immunochemotherapy plus radiotherapy prolonged the survival of metastatic NPC.•A scoring model could facilitate individualized treatment in the era of immunotherapy.•The toxicities of patients receiving combination therapy were tolerable.
MoreTranslated text
Key words
De novo metastatic nasopharyngeal carcinoma,Immunochemotherapy,Locoregional radiotherapy,Response,Survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined